---
figid: PMC9162805__fphar-13-888588-g003
figtitle: 'IKKE in the Metabolic Diseases: Physiology, Pathophysiology, and Pharmacology'
organisms:
- Homo sapiens
- Mus musculus
- Enterovirus A71
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9162805
filename: fphar-13-888588-g003.jpg
figlink: /pmc/articles/PMC9162805/figure/F3/
number: F3
caption: Potential mechanisms of IKKε in diseases. 1) IKKε may induce inflammation
  through the NF-κB pathway, leading to rheumatoid arthritis. 2) IKKε in hepatic stellate
  cells (HSCs) activates the NF-κB pathway to secrete cytokines such as IL-1α, which
  inhibits the insulin signaling pathway in hepatic cells and interferes with glucose
  and lipid metabolism. 3) IKKε is involved in innate immune responses by phosphorylating
  interferon regulatory factor 3 (IRF3) and interferon regulatory factor 7 (IRF7).
  DDX3 enhances the phosphorylation of IKKε and promotes phosphorylation of IRF3,
  and eventually promotes IFNβ promoter activation. 4) IKKε is activated by PDE-3B
  phosphorylated at serine 318. Activated PDE-3B reduces cAMP content in adipocytes
  and inhibits uncoupling protein-1 (UCP1) gene transcription, improving the resistance
  of adipocytes to catecholamines and inducing obesity.
papertitle: 'Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology,
  and Pharmacology.'
reftext: Qing-Ao Xiao, et al. Front Pharmacol. 2022;13:888588.
year: '2022'
doi: 10.3389/fphar.2022.888588
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: inhibitor of nuclear factor kappa-B kinase ε | nonalcoholic fatty liver
  disease | diabetes | obesity | metabolic diseases | amlexanox
automl_pathway: 0.9485241
figid_alias: PMC9162805__F3
figtype: Figure
redirect_from: /figures/PMC9162805__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9162805__fphar-13-888588-g003.html
  '@type': Dataset
  description: Potential mechanisms of IKKε in diseases. 1) IKKε may induce inflammation
    through the NF-κB pathway, leading to rheumatoid arthritis. 2) IKKε in hepatic
    stellate cells (HSCs) activates the NF-κB pathway to secrete cytokines such as
    IL-1α, which inhibits the insulin signaling pathway in hepatic cells and interferes
    with glucose and lipid metabolism. 3) IKKε is involved in innate immune responses
    by phosphorylating interferon regulatory factor 3 (IRF3) and interferon regulatory
    factor 7 (IRF7). DDX3 enhances the phosphorylation of IKKε and promotes phosphorylation
    of IRF3, and eventually promotes IFNβ promoter activation. 4) IKKε is activated
    by PDE-3B phosphorylated at serine 318. Activated PDE-3B reduces cAMP content
    in adipocytes and inhibits uncoupling protein-1 (UCP1) gene transcription, improving
    the resistance of adipocytes to catecholamines and inducing obesity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - IRF6
  - IKBKE
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - TNF
  - IL1A
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - TANK
  - TBKBP1
  - IRF7
  - IRF3
  - IFNB1
  - DDX3X
  - DHX33
  - PDE3B
  - Nfkb1
  - Tlr4
  - Ikbke
  - Nfkbib
  - Rela
  - Gorasp1
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Tnf
  - Il1a
  - Pik3r1
  - Akt1
  - Tank
  - Tbkbp1
  - Irf7
  - Irf3
  - Ifnb1
  - Ddx3x
  - Dhx33
  - Pde3b
  - rela
  - nfkb1
  - tnfb
  - tank
  - irf7
  - irf3
  - ddx3xa
  - pde3b
---
